The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Aphria has an asset utilization ratio of 71.95 percent. This suggests that the company is making $0.72 for each dollar of assets. An increasing asset utilization means that Aphria Inc is more efficient with each dollar of assets it utilizes for everyday operations.
About
19.0% of the company shares are held by institutions such as insurance companies. The book value of Aphria was presently reported as 4.74. Aphria Inc recorded a loss per share of
0.63. The entity had not issued any dividends in recent years.
Use Technical Analysis to project Aphria expected Price
Aphria technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, delisted stock market cycles, or different charting patterns.
A focus of Aphria technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Aphria trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions.
More Info...What is the case for Aphria Investors
This firm reported the previous year's revenue of 477.1
M. Net Loss for the year was (173.48
M) with profit before overhead, payroll, taxes, and interest of 190.97
M.
Deferred Revenue Breakdown
Aphria Deferred Revenue is increasing over the years with very volatile fluctuation. Ongoing Deferred Revenue is projected to grow to about 1.1
M this year. Deferred Revenue usually refers to a component of Total Liabilities representing the carrying amount of consideration received or receivable on potential earnings that were not recognized as revenue; including sales; license fees; and royalties; but excluding interest income. Aphria Deferred Revenue is projected to increase significantly based on the last few years of reporting. The past year's Deferred Revenue was at 1.04 Million
| 2010 | 2.8 Million |
| 2017 | 2.61 Million |
| 2018 | 23.68 Million |
| 2019 | 902,000 |
| 2020 | 1.04 Million |
| 2021 | 1.06 Million |
Aphria has a good chance to finish above $16.6 in 2 months
Current value at risk is at -8.09. Aphria Inc is displaying above-average volatility over the selected time horizon. Investors should scrutinize Aphria Inc independently to ensure intended market timing strategies are aligned with expectations about Aphria volatility. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Aphria's stock risk against market volatility during both bullying and bearish trends. The higher level of volatility that comes with bear markets can directly impact Aphria's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different stocks as prices fall.
Our Conclusion on Aphria
Whereas many of the other players in the drug manufacturers—specialty & generic industry are either recovering or due for a correction, Aphria may not be as strong as the others in terms of longer-term growth potentials. While some in two-three weeks oriented investors may not share our view, we believe it may not be a good time to pick up new shares of Aphria.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectEditorial Staff
Rifka Kats is a Member of Macroaxis Editorial Board. Rifka writes about retail product and service companies from the perspective of a regular consumer and sophisticated investor at the same time. She is passionate about corporate ethics and equality in the workforce.
View Profile This story should be regarded as informational only and should not be considered a solicitation to sell or buy any financial products. Macroaxis does not express any opinion as to the present or future value of any investments referred to in this post. This post may not be reproduced without the consent of Macroaxis LLC. Macroaxis LLC and Rifka Kats do not own shares of Aphria Inc. Please refer to our
Terms of Use for any information regarding our disclosure principles.
Would you like to provide feedback on the content of this article?
You can get in touch with us directly or send us a quick note via email to
editors@macroaxis.com
